We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

136 hedge funds and large institutions have $395M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

1% more funds holding

Funds holding: 134 → 136 (+2)

5% less capital invested

Capital invested by funds: $418M → $395M (-$22.1M)

Holders
136
Holders Change
+2
Holders Change %
+1.49%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
62
Reduced
33
Closed
19
Calls
$426K
Puts
–
Net Calls
+$426K
Net Calls Change
+$425K

Top Buyers

Rank Fund Capital Flow
1
CC
Carlson Capital
Texas
+$16.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$9.69M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.04M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$6.24M
5
PCM
Penn Capital Management
Pennsylvania
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$27.8M
2
Franklin Resources
Franklin Resources
California
-$17.1M
3
TA
Tamarack Advisers
California
-$7.16M
4
EAM
EverPoint Asset Management
Connecticut
-$7.01M
5
Millennium Management
Millennium Management
New York
-$5.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
LIA
126
LS Investment Advisors
Michigan
$9K – – –
UBS Group
127
UBS Group
Switzerland
$8K -$20.6K -1,472 -71%
TRCT
128
Tower Research Capital (TRC)
New York
$6K +$6.69K +477 New
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$4K – – –
DADC
130
D.A. Davidson & Co
Montana
$3K – – –
Geode Capital Management
131
Geode Capital Management
Massachusetts
$2.16K +$367K +26,189 +17%
GT
132
Glenmede Trust
Pennsylvania
$2K – – –
PNC Financial Services Group
133
PNC Financial Services Group
Pennsylvania
$1K -$14.6K -1,039 -90%
Creative Planning
134
Creative Planning
Kansas
$1K – – –
TWA
135
TCI Wealth Advisors
Arizona
$1K +$1.11K +79 New
MFS
136
MSI Financial Services
Massachusetts
$1K +$1.42K +101 New
HM
137
HealthCor Management
New York
– -$27.8M -1,750,000 Closed
TA
138
Tamarack Advisers
California
– -$7.16M -450,000 Closed
RPAM
139
Rhenman & Partners Asset Management
Sweden
– -$2.39M -150,000 Closed
ACP
140
Acuta Capital Partners
California
– -$2.3M -144,667 Closed
WA
141
Whitebox Advisors
Minnesota
– -$1.25M -78,572 Closed
SM
142
Senvest Management
New York
– -$587K -36,919 Closed
LCM
143
Landscape Capital Management
New Jersey
– -$451K -28,377 Closed
Citadel Advisors
144
Citadel Advisors
Florida
– -$379K -23,799 Closed
WMSA
145
Weiss Multi-Strategy Advisers
New York
– -$318K -20,000 Closed
QSS
146
Quantitative Systematic Strategies
Florida
– -$303K -19,090 Closed
CL
147
Croft-Leominster
Maryland
– -$278K -17,500 Closed
UBS AM
148
UBS AM
Illinois
– -$169K -10,600 Closed
SCA
149
Secor Capital Advisors
New York
– -$164K -10,290 Closed
KBC Group
150
KBC Group
Belgium
– -$158K -9,957 Closed
3 4 5
6
7

SGNT Hedge Fund Activity: Q1 2016 in Review

136 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2016, worth a combined $395M — down 5.3% from $418M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGNT positions and 19 closed out — a net gain of 3 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Carlson Capital, opening a new position worth an estimated $16.7M. The largest seller was HealthCor Management, exiting entirely with an estimated $27.8M sold.

  • 136 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2016, up from 134 in Q4 2015.
  • Funds reported $395M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2016, down 5.3% quarter-over-quarter.
  • 22 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2016 and 19 closed out, a net change of +3 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2016 was Carlson Capital, an estimated $16.7M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2016 was HealthCor Management, an estimated $27.8M sold.

Based on aggregated 13F filings for Q1 2016.